SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Table: Apex Biotechnology Sep Rev NT$139.4M Vs NT$181.1M

Apex Biotechnology Corp. - Taiwan Figures in New Taiwan dollars. 2026 2025 Revenue NT$139,373,000 NT$181,084,000 Jan-Sep Revenue NT$1,418,672,000 NT$1,505,913,000 Source: Taiwan Stock Exchange This conten…

1733